Back
Abbott Laboratories (ABT)
Health CareABT · NEW YORK STOCK EXCHANGE, INC. · USD
New to investing? How to read this page →$99.62
+1.15%Weekly undervalued picks
Price · 1 year
Loading live analysis…
Loading analysis…
Intrinsic Investor is for research and education only. Not financial advice.
Key metrics
EPS
$3.73
ROE
12.3%
Gross margin
56.5%
Debt/Equity
0.65x
Revenue growth
7.8%
Abbott Laboratories — company intelligence
Earnings surprises
Q2 2026$1.31 vs $1.29 est+1.4%
Q1 2026$1.15 vs $1.16 est-0.5%
Q4 2025$1.50 vs $1.51 est-0.7%
Q3 2025$1.30 vs $1.31 est-1.1%
Analyst consensus · 33 analysts
25 Buy8 Hold0 Sell
Updated Oct 8, 2026
Insider activity · 90 days
6 buys7 sellsnet -455,897 shares
Ahuja NitaBuy 318 · Sep 30, 2026
Conroy Kevin TBuy 318 · Sep 30, 2026
Gonzalez Patricia PaolaBuy 333 · Sep 30, 2026
Recent SEC filings
4 — Insider transaction reportSep 3, 2026
4 — Insider transaction reportSep 3, 2026
4 — Insider transaction reportAug 27, 2026
Latest news
Abbott Faces $384 Million Cost as Infant Formula Legal Risks Persist — Yahoo · 3w ago
First Canadian Commercial Use of Abbott's Volt™ Pulsed Field Ablation System Advances Minimally Invasive Atrial Fibrillation Care — Yahoo · 3w ago
Abbott (ABT) Rises As Market Takes a Dip: Key Facts — Yahoo · 3w ago
Sector Update: Healthcare Stocks Gain Late Afternoon — Yahoo · 3w ago
AI Valuation Narrative
Generates a short bull / bear / catalyst summary from the analytics we already computed. No target prices. Research tool, not investment advice.
Explore more
Peers & similar stocks
Quick links to related tickers for research.
Weekly undervalued picks
Get 3 new value ideas and the fair-value math behind them every week. One email, unsubscribe anytime.
Free. No spam. We only email once per week.
Data is provided "as-is" and may be delayed or incomplete. Intrinsic Investor is for education only and is not investment advice.